Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care TreatmentNCT06247085TVTXPhase 3Recruiting2027-08Estimated
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)NCT06263231INTSPhase 3Recruiting2027-12Estimated
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]NCT06264180Replimune, Inc.Phase 3Recruiting2030-09-30Estimated
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)NCT06270836KODPhase 3Completed2026-02-13Actual
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801Gossamer Bio USA, Inc.Phase 3Recruiting2026-12Estimated
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in AdultsNCT06279871Arcturus Therapeutics, Inc.Phase 3Completed2024-10-09Actual
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtNCT06282458VERUPhase 2Completed2025-04-11Actual
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerNCT06282575Jazz PharmaceuticalsPhase 3Recruiting2028-12-01Estimated
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineNCT06291857NovavaxPhase 3Completed2025-12-24Actual
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsNCT06292923TLSAPhase 2Active not recruiting2026-09Estimated
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCCNCT06295731INBXPhase 2, Phase 3Active not recruiting2029-05Estimated
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT06296966Vanda PharmaceuticalsPhase 2Unknown2024-07Estimated
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal HemoglobinuriaNCT06298955Omeros CorporationPhase 2Active not recruiting2026-12Estimated
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)NCT06302348PTC TherapeuticsPhase 3Recruiting2031-02-28Estimated
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.NCT06319456Ascentage Pharma Group Inc.Phase 3Recruiting2027-08Estimated
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainNCT06325566MESOPhase 3Active not recruiting2027-07Estimated
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic SclerosisNCT06328777Cabaletta BioPhase 2, Phase 3Recruiting2029-07Estimated
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisNCT06329401AVLNPhase 2Active not recruiting2027-06Estimated
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder CancerNCT06331299URGNPhase 3Active not recruiting2025-09-11Actual
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesNCT06334133vTv TherapeuticsPhase 3Active not recruiting2027-04Estimated
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)NCT06335173Acumen PharmaceuticalsPhase 2Active not recruiting2026-10Estimated
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)NCT06340360NKTRPhase 2Completed2025-11-26Actual
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)NCT06342947Aligos TherapeuticsPhase 2Completed2024-08-19Actual
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)NCT06346067ERASPhase 3Active not recruiting2028-04Estimated
Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaNCT06347003Arrowhead PharmaceuticalsPhase 3Active not recruiting2026-06-12Actual
Study of Plozasiran in Adults With Severe HypertriglyceridemiaNCT06347016Arrowhead PharmaceuticalsPhase 3Active not recruiting2026-06-17Actual
Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaNCT06347133Arrowhead PharmaceuticalsPhase 3Completed2026-06-01Actual
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)NCT06347159EWTXPhase 2Active not recruiting2027-12Estimated
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)NCT06358651VTGNPhase 3Active not recruiting2025-10-31Actual
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)NCT06358950Alkermes, Inc.Phase 2Completed2025-06-19Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.